Copied from under "Abstract" paragraph: Palbociclib, 5-days-on/2-days-off weekly, met its primary endpoint with reduced G3 + ANC, without compromising efficacy. sTK1 is prognostic and shows promise in monitoring the palbociclib response. ClinicalTrials.gov#: NCT3007979.
Here's the whole article. If I could remember who was asking for this, I would have sent to you directly! God bless you and heal us all in Jesus name, amen. PS I have been on this schedule for 10 mos. and doing very well. PS. My onc said "no" to this also, my body my choice! QOL here!